Evidence map›Paper›PMID 40469153›Full record

ArticlePakistan journal of medical sciences2025

Clinical Outcomes of Upper Eyelid Blepharoplasty.

Murtaza Sameen, Rebecca

Abstract read
In one paragraph

Article in Pakistan journal of medical sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Murtaza SameenMurtaza Sameen Assistant Professor, Al Shifa Trust Eye Hospital, Rawalpindi, Pakistan.
RebeccaRebecca Senior Registrar, Al Shifa Trust Eye Hospital, Rawalpindi, Pakistan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: To observe effect of surgery on upper eyelid blepharoplasty in an Asian population. Methods: This retrospective study was conducted at Armed Forces Institute of Ophthalmology from May 2023 to July 2023. This study included patients from 30 to 70 years of age. Patients with upper double eye lid (dermatochalasis) and xanthelasma were included in this study. Patients were counseled about the risk of surgery. Subcutaneous 0.5% lignocaine, approximately 0.6 ml was given after skin marking in each eye. Distance between eyelid margin and inferior margin eyebrow was marked 21mm, to avoid lagophthalmos. Wound approximation was done with 7-0 vicryl interrupted sutures. Follow up was done at day one and two weeks after upper lid blepharoplasty. Results: After a follow up of 02 weeks of 35 subjects who underwent upper eyelid blepharoplasty, 24(68.4%) were females while 11(31.4%) were males. The mean average age + SD in years was 53.45± 1.06. All subjects underwent bilateral upper eyelid blepharoplasty in one sitting. Redo surgery was done in one (2.84%) subject after six months. Eyelid oedema was Grade-II on day one postoperatively and was absent after two weeks of follow up in all subjects. However, no lagophthalmos was seen in any of the subject. Conclusion: Upper Eyelid blepharoplasty is the procedure of choice of correcting double eyelid and xanthelasma. It not only improves periorbital cosmesis but also plays an important part in improving patient vision and contrast.

Indexed as

Aesthetic SurgeryBlepharoplastyDermatochalasisUpper eyelidXanthelasma

Identifiers

PMID40469153
PMCPMC12130937

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.